133 related articles for article (PubMed ID: 17898788)
1. Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody.
Callens C; Moura IC; Lepelletier Y; Coulon S; Renand A; Dussiot M; Ghez D; Benhamou M; Monteiro RC; Bazarbachi A; Hermine O
Leukemia; 2008 Jan; 22(1):42-8. PubMed ID: 17898788
[TBL] [Abstract][Full Text] [Related]
2. A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients.
Moura IC; Lepelletier Y; Arnulf B; England P; Baude C; Beaumont C; Bazarbachi A; Benhamou M; Monteiro RC; Hermine O
Blood; 2004 Mar; 103(5):1838-45. PubMed ID: 14592824
[TBL] [Abstract][Full Text] [Related]
3. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
4. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
[TBL] [Abstract][Full Text] [Related]
5. Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments.
Lepelletier Y; Camara-Clayette V; Jin H; Hermant A; Coulon S; Dussiot M; Arcos-Fajardo M; Baude C; Canionni D; Delarue R; Brousse N; Benaroch P; Benhamou M; Ribrag V; Monteiro RC; Moura IC; Hermine O
Cancer Res; 2007 Feb; 67(3):1145-54. PubMed ID: 17283149
[TBL] [Abstract][Full Text] [Related]
6. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
[TBL] [Abstract][Full Text] [Related]
7. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.
Ishii T; Ishida T; Utsunomiya A; Inagaki A; Yano H; Komatsu H; Iida S; Imada K; Uchiyama T; Akinaga S; Shitara K; Ueda R
Clin Cancer Res; 2010 Mar; 16(5):1520-31. PubMed ID: 20160057
[TBL] [Abstract][Full Text] [Related]
8. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.
Ishida T; Iida S; Akatsuka Y; Ishii T; Miyazaki M; Komatsu H; Inagaki H; Okada N; Fujita T; Shitara K; Akinaga S; Takahashi T; Utsunomiya A; Ueda R
Clin Cancer Res; 2004 Nov; 10(22):7529-39. PubMed ID: 15569983
[TBL] [Abstract][Full Text] [Related]
9. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
10. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
12. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
13. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy.
Waldmann TA
Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734
[TBL] [Abstract][Full Text] [Related]
14. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
[TBL] [Abstract][Full Text] [Related]
15. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
Waldmann TA; Greene WC; Sarin PS; Saxinger C; Blayney DW; Blattner WA; Goldman CK; Bongiovanni K; Sharrow S; Depper JM
J Clin Invest; 1984 Jun; 73(6):1711-8. PubMed ID: 6327770
[TBL] [Abstract][Full Text] [Related]
16. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
[TBL] [Abstract][Full Text] [Related]
17. Induction of T cell activation by monoclonal antibodies specific for the transferrin receptor.
Cano E; Pizarro A; Redondo JM; Sánchez-Madrid F; Bernabeu C; Fresno M
Eur J Immunol; 1990 Apr; 20(4):765-70. PubMed ID: 2140787
[TBL] [Abstract][Full Text] [Related]
18. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
Boldt DH; Phillips JL; Alcantara O
J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
[TBL] [Abstract][Full Text] [Related]
19. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors.
Bjorn MJ; Groetsema G
Cancer Res; 1987 Dec; 47(24 Pt 1):6639-45. PubMed ID: 3499979
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]